Sasikiran Nunna

Sasikiran Nunna has extensive work experience in the field of healthcare market research and value evidence strategy. Sasikiran is currently serving as the Director of Global Value Evidence Strategy at Otsuka Pharmaceutical Companies (U.S.) since September 2022. Prior to this, from April 2021 to September 2022, they worked as an Associate Director of Global Value & Real-World Evidence at the same company.

Before joining Otsuka Pharmaceutical Companies, Sasikiran worked at Bristol Myers Squibb as a member of the Real World Evidence Strategy team from July 2020 to April 2021.

Sasikiran gained valuable experience at IQVIA, where they held multiple roles. From May 2019 to July 2020, they worked as a Senior Consultant in Health Economics and Outcomes Research (HEOR), and from September 2017 to April 2019, they served as a Consultant in the same domain.

Sasikiran's career began with their role as a Research Assistant for the MS Medicaid Drug Utilization Review program at the University of Mississippi from January 2013 to August 2017.

Sasikiran has also contributed their skills and knowledge to AbbVie as an HEOR Analyst for a brief period from September to December 2016, and as an HEOR Intern from June to August 2016.

Furthermore, they gained experience as an HEOR Intern at Xcenda from June to August 2015.

Earlier in their career, Sasikiran worked as a Junior Consultant at IQVIA from July 2011 to July 2012, and as an Associate Analyst at GlobalData from June 2010 to July 2011.

Sasikiran Nunna completed a B.Pharm (Hons) degree in Pharmaceutical Sciences from Birla Institute of Technology and Science, Pilani in 2006-2010. Later, they pursued a Master's Degree and Doctor of Philosophy (Ph.D.) in Health Economics and Outcomes Research from the University of Mississippi from 2012 to 2017.